BioPhoria

We envision a world where drug delivery is not just about administering medication but ensuring optimal bioavailability, tailored treatment, and patient-centric care. We aim to lead the global pharmaceutical industry by consistently pushing the boundaries of innovation, addressing critical healthcare challenges, and fostering partnerships that transform lives. BioPhoria is revolutionizing pharmaceutical care with its pioneering drug delivery systems. As pioneers in the Ketamine industry, we introduced the world's first dry powder inhalable Ketamine featuring BioPhoria Control™, our rapid onset, pH-target released, technology delivering up to 65% bioavailability. Our patented microencapsulated and enteric coated formulation process is used to create commercialized inhalable and ingestible ketamine products allowing for up to 95% bioavailability, as well as for research in other Therapeutics, Psychedelics, and Alternative Medicines.